Career paths for cardiologists in industry: pharmaceutical, medical insurance, health technology and management consulting
Cardiologists have opportunities to transition to different roles outside of traditional clinical care. In this article, we describe the potential opportunities for cardiologists in pharmaceutical, medical insurance, health technology and management consulting. We highlight some unique considerations for each industry and discuss a strategic approach to engage in these opportunities.
New AHA Statement on Ischemia After Cardiac Surgery
The American Heart Association (AHA) outlines "considerations" on the management of acute postoperative myocardial ischemia (PMI) after cardiac surgery in a scientific statement.
New Clinical Practice Guideline for the Management of Adult Overweight and Obesity
Synopsis summarizes the key recommendations of the guideline regarding management of overweight and obesity, including referral to comprehensive lifestyle interventions that combine behavioral, dietary, and physical activity change, and additional tools of pharmacologic and procedural interventions.
HFA CONFERENCE NEWS June 29 - July 01, 2021, Virtual
IV Iron Can Save Costs in HF With Iron Deficiency in Analysis;
HF Med Undertreatment Due to Older Age Common, Flouts Evidence;
Iron-Clad Benefits of CRT Seen in Reduced-EF Heart Failure;
Assays May Guide SGLT2 Inhibitor Use in High CV-Risk Diabetes
"COVID-19 and cardiovascular diseases: main aspects" The report of Igor S. Yavelov MD, PhD, Professor of cardiology
CV risk factors and CVD are present in many patients with COVID-19 and their presence is associated with an increased risk of cardiovascular complications with new coronavirus infection.
Young adults who lost and then restored heart health had lower risk of heart attack, stroke
A long-term analysis of young adults in Korea found that those with poor heart health had higher rates of cardiovascular disease at a younger age.
EAS Helsinki 2021 Virtual. THE RISE OF CARDIOMETABOLIC DISEASE
Not only are we living in a COVID-19 pandemic, but also an accelerating pandemic of cardiometabolic disease, requiring renewed focus. The third plenary session discussed options to address this escalation in cardiometabolic disease.
COVID-19 vaccine benefits still outweigh risks, despite possible rare heart complications. Statement from the American Heart Association/American Stroke Association
Late last week, the U.S. Centers for Disease Control and Prevention (CDC) alerted health care professionals that they are monitoring the Vaccine Adverse Events Reporting System (VAERS) and the Vaccine Safety Datalink (VSD) for cases of young adults developing the rare heart-related complication myocarditis, after receiving a COVID-19 vaccine manufactured by Pfizer-BioNTech or Moderna.
Administration of patients during and after a coronavirus pandemic. Interview with professor Mekhman N. Mamedov.
Dear Colleagues! On April 27, 2021, at the initiative of the Indonesian Society of Cardiology, an online meeting was held with one of the leading experts of Russia in the cardiology, Professor Mekhman N. Mamedov
RU
EN